HANNOVER, Germany--(BUSINESS WIRE)--The three finalists of the 2008 EUROPEAN BIOTECHNICA AWARD have been determined. The biotechnology companies nominated are Cambridge-based Astex Therapeutics Limited (UK), GENEART AG from Regensburg (Germany) and immatics biotechnologies GmbH based in Tübingen (Germany). The prize, worth EUR 100,000, is awarded to innovative European biotechnology and life sciences companies. “Innovation capacity is the driving force behind the economic success of one of the most important sectors of the future. With the EUROPEAN BIOTECHNICA AWARD, we are supporting upcoming biotechnology firms which, thanks to their dedication, make a significant contribution to the development of Europe as a research location”, emphasized Stephan Kühne, Board member of Deutsche Messe AG. This year will mark the sixth anniversary of the award presented by Deutsche Messe AG and partners.
